For the first time in three decades, researchers believe they have identified a new class of antibiotics.
Teams at McMaster University in Ontario, Canada and the University of Illinois, Chicago — led by researcher Gerry Wright — collaborated in the discovery of lariocidin, which was found to be effective against drug-resistant bacteria.
The results were published this week in the journal Nature.
SUPERBUGS DUE TO ANTIBIOTIC RESISTANCE COULD KILL 39 MILLION PEOPLE BY 2050, LARGE STUDY FINDS
Lariocidin is a lasso peptide, a string of amino acids in a lasso shape that attacks bacteria and keeps it from growing and surviving, according to a McMaster press release.
It is produced by a type of bacteria called Paenibacillus, which the researchers retrieved from a local backyard soil sample and cultivated in a lab for one year.
Paenibacillus was found to produce a new substance that attacks antibiotic-resistant bacteria.
“Lariocidine is not susceptible to many of the mechanisms that make disease-causing…